Loading...
•
Sep 30, 2022
Biolase Q3 2022 Earnings Report
Reported 26% revenue growth year over year.
Key Takeaways
BIOLASE, Inc. announced its financial results for the third quarter ended September 30, 2022, with total revenue of $12.0 million, up 26% year over year. U.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year. The company is increasing its 2022 full year revenue guidance and now expects full year net revenue to increase at least 20% from 2021 levels.
Total revenue was $12.0 million, up 26% year over year
U.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year, driven by increased procedures using BIOLASE lasers
Over 90% of U.S. Waterlase sales coming from new customers and approximately 40% of U.S. Waterlase sales coming from dental specialists
Waterlase Exclusive Trial Program success rate remained at over 50% year to date, highlighting the program’s success
Revenue by Segment
Forward Guidance
BIOLASE is anticipating fourth quarter net revenue to exceed $13.0 million, which would represent growth of at least 5% year over year. The Company is increasing its 2022 full year revenue guidance and now expects full year net revenue to increase at least 20% from 2021 levels.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...